Daniel Goldberg

(Part four of a four-part series) See previous stories in this series:  Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities  Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo, Public Market Valuations &...

(Part two of a four-part series) See the previous story in this series: EXCLUSIVE Insider's Peek At Mammoth Of Psychedelics VCs, Palo Santo's Investment Fundamentals & Specificities    The Palo Santo venture fund invests in private companies. As such,...

(Part one of a four-part series) Daniel Goldberg and Tim Schlidt are co-founders and partners behind Palo Santo, one of the most remarkable VC funds investing in psychedelics today. The company recently closed a capital round of $50 million for investment in a diverse portfolio...

Palo Santo, a venture capital fund focused on backing and building emerging psychedelic therapeutics companies, recently announced the closing of its $50 million fund. The oversubscribed fund is positioned to have a transformative impact on the field of mental health by funding a diverse portfolio...